• Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Average Rating of "Moderate Buy" from Analysts

    Source: Buzz FX / 22 Nov 2024 01:56:08   America/Chicago


    Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Average Rating of "Moderate Buy" from Analysts Written by MarketBeat November 22, 2024 Share Link copied to clipboard. Nurix Therapeutics, Inc. ( NASDAQ:NRIX - Get Free Report ) has been assig
    Read more...
Share on,